Trials
Search / Trial NCT05649969

STRONG Program for Cancer Patients

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Dec 6, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Active, not recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer)
  • • Peritoneal disease diagnosis
  • • Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt
  • • Transitioned to an oral diet post-surgery
  • • Able to speak and read English
  • • Able to provide informed consent
  • Exclusion Criteria:
  • • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
  • • Undergoing concurrent treatment for a secondary primary cancer
  • • Receipt of parenteral or enteral nutrition after surgery

Trial Officials

Amir Alishahi Tabriz, MD, PhD, MPH

Principal Investigator

Moffitt Cancer Center

Ben Powers, MD

Principal Investigator

Moffitt Cancer Center

About H. Lee Moffitt Cancer Center And Research Institute

H. Lee Moffitt Cancer Center and Research Institute is a leading institution dedicated to cancer research, treatment, and education, recognized for its commitment to advancing cancer care through innovative clinical trials and groundbreaking research. As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt integrates cutting-edge science with patient-centered care, offering a multidisciplinary approach to cancer treatment. The center is at the forefront of developing novel therapies and improving outcomes for patients, emphasizing collaboration between researchers and clinicians to translate scientific discoveries into effective treatments. Through its extensive clinical trial programs, Moffitt aims to enhance the understanding of cancer biology and provide patients with access to the latest therapies and interventions.

Locations

Tampa, Florida, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials